Stimulation and inhibition of ACTH release in patients with pituitary disease.
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine; D000172:Acromegaly / Q000503:physiopathology; D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000328:Adult; D000368:Aged; D003907:Dexamethasone; D003919:Diabetes Insipidus / Q000503:physiopathology; D005246:Feedback; D005260:Female; D006801:Humans; D006849:Hydrocephalus; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D007037:Hypothyroidism / Q000503:physiopathology; D007713:Klinefelter Syndrome; D008297:Male; D008875:Middle Aged; D010900:Pituitary Diseases / Q000503:physiopathology*; D010912:Pituitary-Adrenal Function Tests; D012658:Sella Turcica; D013974:Thyroxine / Q000627:therapeutic use; D014044:Tolbutamide / Q000627:therapeutic use
D015065:17-Hydroxycorticosteroids; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D014044:Tolbutamide; D013974:Thyroxine